Oculoplastics News

Most adults with thyroid eye disease who experienced meaningful improvement in proptosis after 21 weeks of teprotumumab treatment maintained proptosis response at week 72 without additional treatment, according to top-line data.

Upneeq 0.1%, a novel treatment for acquired blepharoptosis, has been approved by the FDA, according to a press release.

IMVT-1401, a thyroid eye disease treatment candidate, showed a 65% improvement in IgG levels in a phase 2a proof-of-concept study, Immunovant announced in a press release.

KOLOA, Hawaii — At Hawaiian Eye 2020, Femida Kherani, MD, shares pearls for incorporating dermal fillers and neuromodulators, such as learning to choose the right filler for the right location.

KOLOA, Hawaii — At Hawaiian Eye 2020, Femida Kherani, MD, FRCSC, discusses the importance of consultation for patients undergoing blepharoplasty. “A great preop consult is essential to your success,” Kherani said.

Adults with thyroid eye disease assigned the human monoclonal antibody teprotumumab were significantly more likely to experience a meaningful improvement in proptosis after 21 weeks of treatment compared with those who received placebo, according to findings from a randomized controlled trial published in The New England Journal of Medicine.

The FDA on Tuesday approved the human monoclonal antibody teprotumumab for the treatment of adults with thyroid eye disease, marking the first drug approved for the condition, according to an agency press release.

KOLOA, Hawaii — Blepharoplasty is the third most common aesthetic surgery and the No. 1 procedure performed on the face, according to a presenter.

KOLOA, Hawaii — Ptosis is a relatively common but under-recognized risk of intraocular surgery, including cataract surgery, according to a presenter at Hawaiian Eye 2020.

KOLOA, Hawaii — At Hawaiian Eye 2020, Andrew R. Harrison, MD, director of plastic surgery and associate professor of ophthalmology at the University of Minnesota, shares his surgical pearls for performing upper blepharoplasty.